Evolus, Inc. (LON:0K16)
14.58
+0.43 (3.00%)
At close: Jan 31, 2025
Evolus Revenue
In the year 2024, Evolus had annual revenue of $266.27M USD with 31.76% growth. Evolus had revenue of $78.95M in the quarter ending December 31, 2024, with 29.42% growth.
Revenue
$266.27M
Revenue Growth
+31.76%
P/S Ratio
2.62
Revenue / Employee
$802.03K
Employees
332
Market Cap
556.56M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 266.27M | 64.19M | 31.76% |
Dec 31, 2023 | 202.09M | 53.47M | 35.98% |
Dec 31, 2022 | 148.62M | 48.94M | 49.10% |
Dec 31, 2021 | 99.67M | 43.13M | 76.29% |
Dec 31, 2020 | 56.54M | 21.62M | 61.89% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
GSK plc | 31.38B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Oxford Nanopore Technologies | 183.19M |
Evolus News
- 4 weeks ago - Evolus to Participate in The Needham 24th Annual Virtual Healthcare Conference - Business Wire
- 5 weeks ago - Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 7 weeks ago - Evolus, Inc. 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 7 weeks ago - Evolus, Inc. (EOLS) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Evolus Inc Reports Q4 2024 Revenue of $79 Million, Surpassing Estimates; EPS Misses at -$0.11 - GuruFocus
- 7 weeks ago - Evolus posts quarterly profit on strong sales of cosmetic injection - Reuters
- 7 weeks ago - Evolus Reports Record Fourth Quarter and Full-Year 2024 Financial Results; Reaffirms 2025 Guidance - Business Wire
- 2 months ago - Evolus to Participate in Fireside Chats and One-on-One Meetings at Upcoming Investor Conferences - Business Wire